IL4I1 and central nervous system cancer: The expression levels of IL4I1 are correlated with reduced survival in glioma patients, and high IL4I1-expressing tumors are characterized by an enrichment of suppressive immune cells (MDSCs) and Tregs; however, the major cell types expressing IL4I1 in glioma were not identified in this study [228].